ArticleTherapeutic advances in medical oncology2016

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors.

Elena Verzoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.